Santhera Announces Publication by ReveraGen of Positive Phase IIa-Extension Study Results with Vamorolone
A publication in the journal Neurology was released today describing efficacy studies of vamorolone, a treatment option being evaluated as a potentially safer alternative to corticosteroids, in people with Duchenne. PPMD is pleased to learn…Learn More